Strength in Dolby Atmos and Dolby Vision, synergies from acquisitions and focus on shareholder returns make DLB an attractive investment opportunity.

Handelsbanken Fonder AB lowered its holdings in Dolby Laboratories, Inc. (NYSE:DLB – Free Report) by 23.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & ...

Cognition Therapeutics also worked with Arjuna Ratnayaka, Ph.D. in the School of Clinical and Experimental Sciences at the University of Southampton to conduct an in vitro study showing the potential ...

Highlight,Updated earnings projections for Q2 2025 and future fiscal years by Zacks Research.,Steady market performance with ...

Masked Analysis Shows Participants Receiving Oral Zervimesine for at Least 6 Months Experienced Slower Lesion Growth than Participants Receiving ...

After competing in regionals for the Northwest Conference (NWC) many wrestlers were given the opportunity to be awarded all ...

Research analysts at Zacks Research increased their Q2 2025 earnings per share estimates for shares of Dolby Laboratories in a note issued to investors on Wednesday, February 19th. Zacks Research ...

Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical stage company developing neurodegenerative disease candidates, (the "Company" or "Cognition") ...

Lakers are rounding out their season with three final games before the state qualifying tournaments start. The Lakers hosted the Nedrose Cardinals Tuesday, February 18 at the Dock. DLB held an overall ...

If you buy and hold a stock for many years, you'd hope to be making a profit. But more than that, you probably want ...

For the purpose of designing the patient-based model for Dementia with Lewy Bodies (DLB), the report provides historical as well as forecasted epidemiology segmented by Total Prevalent Cases of ...

today provided an update on its neflamapimod development program in dementia with Lewy bodies (DLB) as part of an oral presentation at the 8 th International Lewy Body Dementia Conference (ILBDC ...